Revelation Biosciences Inc. Announces Exercise of Warrants for $9.6 Million in Gross Proceeds

Core Insights - Revelation Biosciences, Inc. has entered into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to 4,355,000 shares of common stock at an exercise price of $2.20 per share [1] Company Summary - The company is a clinical-stage life sciences firm focused on rebalancing inflammation [1] - The existing warrants were issued on May 29, 2025, and the shares are registered under an effective registration statement on Form S-1 [1]